Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol to treat tachycardia in septic shock
2010-023495-11Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esmolol in septic shock, sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoint: Vasopressor requirements. Started Feb 2011; status: active.
02
Drugs
esmolol
03
Conditions
septic shock
Beyond the preview
Go deeper on 2010-023495-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023495-11.